Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002563150 | SCV001401254 | uncertain significance | Developmental and epileptic encephalopathy, 54 | 2019-08-23 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine with valine at codon 652 of the HNRNPU protein (p.Ile652Val). The isoleucine residue is highly conserved and there is a small physicochemical difference between isoleucine and valine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with HNRNPU-related conditions. This variant is not present in population databases (ExAC no frequency). |